Skip to main content
Molecular Plant Pathology logoLink to Molecular Plant Pathology
. 2008 Oct 30;10(1):69–80. doi: 10.1111/j.1364-3703.2008.00511.x

Identification of new type III effectors and analysis of the plant response by competitive index

ALBERTO P MACHO 1, JAVIER RUIZ‐ALBERT 1, PABLO TORNERO 2, CARMEN R BEUZÓN 1,
PMCID: PMC6640233  PMID: 19161354

SUMMARY

In recent years, many efforts have been directed towards the identification of new type III‐secreted effectors, and the completion of the secretomes of several Pseudomonas syringae pathovars. Several functional and bioinformatic screenings have been used to search for candidates, which have been tested for translocation into the plant cell, an essential criterion for the identification of new type III effector proteins. The most common translocation assay is based on the use of ΔAvrRpt2 as a reporter. When fused to a type III effector protein, ΔAvrRpt2 is translocated and elicits a hypersensitive response in leaves of Arabidopsis thaliana expressing the RPS2 resistance protein. This approach has been used widely and has allowed the identification of a considerable number of new effectors in a fast and convenient manner. However, as the hypersensitive response is a semi‐quantitative assay, and the conditions do not resemble those occurring in nature, effectors with low expression or translocation efficiency could fail to translocate sufficient ΔAvrRpt2 to trigger a clear hypersensitive response. In keeping with these limitations, this test has failed to detect some true effectors that have been confirmed as such by other means. In order to increase the sensitivity of this method, we have developed a modification of the ΔAvrRpt2‐based translocation assay using a competitive index in mixed infection to monitor the limitation of growth associated with the induction of the hypersensitive response. We have tested several effector candidates from P. syringae pv. phaseolicola and other P. syringae pathovars, and have compared the results obtained by our competitive index translocation assay with those obtained by standard hypersensitive response assays. We have identified six type III secretion system‐translocated proteins using this approach, five of which failed to be identified by hypersensitive response assays. In addition, we have analysed the defence response triggered by one of these effectors using competitive index assays.

INTRODUCTION

Pseudomonas syringae is a Gram‐negative, host‐specific pathogen that depends on the hypersensitive response and pathogenicity (Hrp) type III secretion system (TTSS) to cause disease in compatible hosts, and to trigger a hypersensitive response (HR) in incompatible hosts (Alfano and Collmer, 1997). TTSS is responsible for the secretion and translocation of effector proteins into the plant cell, where they modulate different cellular processes. The specificity of the TTSS‐mediated interaction is based on the set of delivered effectors translocated by each strain, called the secretome (Alfano and Collmer, 2004). In recent years, many efforts have been directed towards the identification of new effectors and the completion of the secretomes of different P. syringae pathovars (Lindeberg et al., 2006). These studies have screened for effector candidates by searching for the presence of putative secretion signals, HrpL‐dependent promoters, or both. Candidates were then tested for their ability to be translocated in a TTSS‐dependent manner. Most common translocation assays are based on the generation of translational fusions between the putative effector gene and the genes encoding either ΔAvrRpt2 (Mudgett et al., 2000) or the adenylate cyclase (hereafter Cya) from Bordetella pertussis (Schechter et al., 2004) as translocation reporters. More than 60 P. syringae effector candidates have been validated using the ΔAvrRpt2 reporter, expressing the protein fusions either from a constitutive (Vinatzer et al., 2006) or a native (Chang et al., 2005) promoter. In this assay, P. syringae strains expressing the fusion proteins are infiltrated into Arabidopsis thaliana which carries a functional copy of the RPS2 resistance gene. Thus, the development of a visible RPS2‐AvrRpt2‐dependent HR indicates that the effector candidate is translocated inside the plant cell. Although this assay has allowed the identification of a considerable number of new effectors, it has certain limitations (Lindeberg et al., 2006). Effectors with low levels of expression or low translocation efficiencies could fail to produce sufficient translocated ΔAvrRpt2 to trigger a clear HR. As the macroscopic HR is a semi‐quantitative assay, some translocated effectors may thus be either below or on the limit of detection of these assays, giving a false‐negative result or a weak or inconsistent HR (Chang et al., 2005; Vinatzer et al., 2005). In keeping with these limitations, there are examples of effectors that, failing to be validated by this assay, have been shown by other methods to be translocated (Lindeberg et al., 2006; Vencato et al., 2006).

In order to increase the sensitivity of the ΔAvrRpt2‐based translocation assay, we have designed a modification of this method. In our assay, we monitor the limitation of bacterial growth associated with a resistance–avirulence (R–avr) interaction, rather than the appearance of visible HR symptoms. Furthermore, we measure bacterial growth by the competitive index of bacteria expressing a ΔAvrRpt2 translational fusion to an effector candidate in mixed infection with the wild‐type strain. We have established previously that an adequate inoculation dose eliminates the risk of interference between co‐inoculated strains (Macho et al., 2007). In this manner, we have shown that the competitive index assay is a more accurate and sensitive measure of bacterial growth within the plant than are traditional growth assays, as a direct comparison between the growth of two strains is carried out in each plant, drastically reducing the experimental variation and increasing the sensitivity (Macho et al., 2007).

In this work, we have applied competitive index‐based translocation assays to the analysis of effector candidates from the fully sequenced P. syringae pv. phaseolicola 1448a strain. Candidates were selected from genes previously reported to be either differentially expressed in planta, or HrpL regulated, or those showing similarities to bona fide effectors from other pathovars. Some of these candidates had previously given negative or inconsistent results using traditional HR assays. We compare the results obtained by competitive index translocation assays with those obtained by standard HR. We demonstrate translocation for six proteins, five of which failed to give a positive result by HR assay. In addition, we analyse the plant response to one of the effectors using competitive index assays, and find that it is partially independent of the response triggered by AvrRpt2.

RESULTS

Sensitivity of competitive index vs. standard HR as translocation assay

This work was started by testing whether the level of gene expression was important for the detection of translocation of ΔAvrRpt2 fusions. First, we assayed the effectiveness of the full AvrRpt2 protein in triggering HR when expressed from a plasmid under either the medium‐ to low‐level expression lactose promoter lacZ or the high‐level expression promoter neomycin phosphotransferase type II (nptII). Arabidopsis wild‐type plants (ecotype Col‐0; RPS2/RPS2) were inoculated with P. syringae pv. tomato (Pto) DC3000 strain (hereafter PtoDC3000) carrying either of these two plasmids. AvrRpt2 expressed from the lacZ promoter did not elicit any HR symptoms (Fig. 1a), nor did it cause any growth attenuation, as the strain expressing the effector grew as much as the co‐inoculated wild‐type strain (competitive index not statistically different from unity; P < 0.05) (Fig. 1b). Actual competitive indices for all the assays carried out in this work are included as ‘Supporting Information’ (Table S1). As the competitive index of a given strain in mixed infection with the wild‐type is calculated as the output ratio between the two strains divided by their input ratio, a competitive index significantly lower than one reflects a growth defect of the strain being tested. Thus, the level of expression provided by the lacZ promoter is not sufficient to trigger an AvrRpt2‐dependent HR detectable by either standard or competitive index assays. However, when AvrRpt2 was expressed from the nptII promoter, it elicited a clear macroscopic HR (Fig. 1a), and caused a 50‐fold attenuation in competitive index assays (Fig. 1b). These results prompted us to test the translocation of the fusion proteins when expressed from the nptII promoter. The reason for this is that the level of expression and translocation of AvrRpt2 required for the effective triggering of HR is considerably high, but does not necessarily reflect the level of expression and translocation required for a given effector to carry out its biological function. We also assayed an AvrRpt2 protein generated by fusing its amino (amino acids 1–80) and carboxy (amino acids 81–255) terminal domains (referred to as N + C AvrRpt2 in the corresponding figures and tables), following the same cloning strategy as used to generate translational fusions to the effector candidates. Thus, this AvrRpt2 version has an insertion of two amino acids encoded by the restriction site used to generate the fusion. The results obtained on expression of this modified AvrRpt2 protein from either the lacZ or nptII promoter were not significantly different from those obtained on expression of the full AvrRpt2 (P < 0.05), ruling out any loss of activity caused by the strategy followed to generate the fusions (Fig. 1).

Figure 1.

Figure 1

Sensitivity of competitive index vs. standard hypersensitive response (HR) as translocation assay. (a) Standard ΔAvrRpt2‐dependent HR translocation assays. PtoDC3000 strains carrying control plasmids (left) or plasmid‐encoded candidate fusions to ΔAvrRpt2 (right) were inoculated into Arabidopsis Col‐0 (RPS2/RPS2) wild‐type at an optical density at 600 nm (OD600) of 0.07, and leaves were scored for HR at 24 h post‐inoculation (hpi). Control plasmids include the full sequence of AvrRpt2, and an AvrRpt2 protein generated by fusing its amino (amino acids 1–80) and carboxy (amino acids 81–255) terminal domains (referred to as N + C AvrRpt2), following the same cloning strategy as used to generate translational fusions to the effector candidates. The photographs illustrate typical symptoms of a minimum of 80 inoculated leaves per experiment. Three independent experiments were performed with similar results. (b) Graphical representation of ΔAvrRpt2‐dependent competitive index‐based translocation assays. PtoDC3000 wild‐type was co‐inoculated into wild‐type plants with PtoDC3000 strains carrying control plasmids (left) or plasmid‐encoded candidate fusions to ΔAvrRpt2 (right). Competitive indices are the mean of three samples, and the error bars represent the standard error. Three independent experiments were performed with similar results. Asterisks indicate results significantly different from one as established by Student's t‐test (P < 0.05), indicating significant attenuation of the strain tested.

To test the sensitivity of competitive index vs. standard HR as translocation assay, we selected some previously tested effector candidates from P. syringae pv. phaseolicola 1448a (hereafter Pph1448a). We chose only those effector candidates that, although expressed in an HrpL‐dependent manner, gave negative translocation results in standard HR assays, discarding those showing a truncation or frameshift when compared with similar effectors from other pathovars. A detailed list of the selected candidates and their relevant information is included in Table 1. We performed standard HR and competitive index assays to test HopJ1Pph1448a, HopV1Pph1448a (expressed with its putative chaperone, ShcV), HopAK1Pph1448a and HopAJ1Pph1448a. In all cases, the full length of the candidate gene was used to generate the translational fusion to the reporter. However, strains expressing a fusion to the full‐length hopAJ1 gene showed retarded growth and abnormal morphology in rich medium (data not shown). Therefore, we used the first 14 amino acids of HopAJ1 instead, as carried out previously by Vinatzer et al. (2005) to analyse the translocation of the homologous effector HopAJ1PmaES4326. In agreement with previous reports (Chang et al., 2005), neither of these candidate fusions triggered a consistent HR (Fig. 1a). Only the fusion of the first 14 amino acids from HopAJ1Pph1448a induced a weak and inconsistent HR, with mild symptoms present in just one‐third of the infiltrated leaves. However, when these candidates were tested by competitive index translocation assays, strains carrying the HopAK1Pph1448a and HopAJ1Pph1448a fusions gave competitive indices significantly different from one (P < 0.05). (Fig. 1b). In other words, the growth of these strains is significantly lower than the growth of the wild‐type (by twofold and fivefold, respectively), and such growth attenuation is likely to be caused by these fusion proteins inducing resistance in the infiltrated plants. Therefore, the fusion proteins are translocated inside the cell, thus showing that these candidates have the necessary secretion and translocation signals to be considered as TTSS substrates.

Table 1.

Pseudomonas syringae effector candidates tested for translocation.

Name or locus Strain Relevant information Reference
HopJ1Pph1448a Pph1448a Negative in previous Δ79AvrRpt2 translocation assay (Chang et al., 2005) (Lindeberg et al., 2005)
Translocated homolog in PmaES4326 (Guttman et al., 2002)
HopV1Pph1448a Pph1448a Negative in previous Δ79AvrRpt2 translocation assay (Chang et al., 2005) (Lindeberg et al., 2005)
Translocated homolog in PtoDC3000 (Schechter et al., 2004)
HopAJ1Pph1448a Pph1448a Negative in previous Δ79AvrRpt2 translocation assay (Chang et al., 2005) (Lindeberg et al., 2005)
Translocated homologue in PmaES4326 (Guttman et al., 2002), first 14 amino acids also shown as translocated by Vinatzer et al. (2005)
Homologue in PtoDC3000 negative in previous Δ79AvrRpt2 (Chang et al., 2005) and Cya (Oh et al., 2007) translocation assays
HopAK1Pph1448a Pph1448a Negative in previous Δ79AvrRpt2 translocation assay (Chang et al., 2005) (Lindeberg et al., 2005)
Translocated homologue in PmaES4326 (Guttman et al., 2002)
Homologue in PtoDC3000 translocated at low levels in previous Cya translocation assay (Kvitko et al., 2007)
HopAH2Pph1448a Pph1448a Translocated homologues in PtoDC3000 (HopAH2‐1, HopAH2‐2) (Schechter et al., 2004; Vinatzer et al., 2005) N/A
HopAJ2Pph1448a Pph1448a Similar to translocated effector HopAJ1PmaES4326 (Lindeberg et al., 2005)
HopAN1Pph1448a Pph1448a Untested homologue in PtoDC3000 (Boch et al., 2002) (Lindeberg et al., 2005)
PSPPH3757 Pph1448a Homologue in PtoDC3000, expressed in planta and untested for translocation, known as ORF24 (Petnicki‐Ocwieja et al., 2002) or Ipx 39–40 (Boch et al., 2002) N/A
A0129Pph1448a Pph1448a Putative HrpL‐activated gene (Vencato et al., 2006)
HopZ1PsyA2 PsyA2 Translocated homologue in PmaES4326 (Guttman et al., 2002) (Sundin et al., 2004)
Avirulence phenotype in Arabidopsis plants (Ma et al., 2006)
HopZ2Ppi895A Ppi895A Avirulence phenotype in bean plants (Arnold et al., 2001)

Competitive index translocation assays of untested candidates

Once we confirmed that the competitive index translocation assay was an effective and sensitive method to demonstrate the translocation of candidate effectors, we applied the method to other Pph1448a candidates to contribute to the completion of its secretome. Since the publication of the Pph1448a genome sequence (Joardar et al., 2005), many candidates have been proposed on the basis of their similarity to effectors from other pathovars. We selected those candidates that, having been proposed as putative TTSS effectors, had not yet been tested for translocation (Table 1). HopAH2Pph1448a, HopAJ2Pph1448a, HopAN1Pph1448a and PSPPH3757 were chosen for testing. We also selected A0129Pph1448a, a putative HrpL‐regulated gene not previously tested for translocation. Standard HR and competitive index assays of the candidate fusions were carried out. None of the Pph1448a candidate fusions elicited a visible HR (Fig. 2a). However, using competitive index translocation assays, HopAH2Pph1448a and A0129Pph1448a fusions showed significant and reproducible attenuation (twofold and fourfold, respectively) (P < 0.05), thus demonstrating that these proteins are translocated (Fig. 2b).

Figure 2.

Figure 2

Translocation assays of previously untested candidates. (a) ΔAvrRpt2‐dependent hypersensitive response (HR) translocation assays. PtoDC3000 strains expressing candidate fusions to ΔAvrRpt2 were inoculated into wild‐type plants at an optical density at 600 nm (OD600) of 0.07, and leaves were scored for HR at 24 h post‐inoculation (hpi). The photographs illustrate typical symptoms of a minimum of 80 inoculated leaves per experiment. Three independent experiments were performed with similar results. (b) Graphical representation of ΔAvrRpt2‐dependent competitive index‐based translocation assays. PtoDC3000 wild‐type was co‐inoculated into wild‐type plants with PtoDC3000 strains expressing candidate fusions to ΔAvrRpt2. Competitive indices correspond to the mean of three samples, and the error bars represent the standard error. The experiments were repeated three times with similar results. Asterisks indicate results significantly different from one as established by Student's t‐test (P < 0.05), indicating significant attenuation of the strain tested.

Competitive index assays in rps2 mutant plants

A positive result in any AvrRpt2‐based translocation assay relies on the recognition of the translocated reporter, ΔAvrRpt2, by a functional RPS2 resistance protein (Mudgett et al., 2000). In keeping with this notion, the attenuation of growth detected by competitive index translocation assays for PtoDC3000 expressing HopAJ1Pph1448a, HopAK1Pph1448a, HopAH2Pph1448a and A0129Pph1448a fusions, as well as the AvrRpt2 controls, should not be detected when the strains are tested in plants lacking a functional copy of RPS2 (rps2/rps2 plants). However, if any of the effector candidates were capable of triggering an RPS2‐independent HR, PtoDC3000 expressing a fusion to that effector would also induce HR in rps2 plants. Figure 3a shows that, when assayed in rps2 plants, the competitive index results of the control strains, as well as the translocated fusions, were not significantly different from one (P < 0.05), indicating that, in all cases, growth attenuation registered in wild‐type plants was only the result of an RPS2‐mediated response. These results also show that the attenuation of growth detected in wild‐type plants is specifically caused by the activation of a defence response, and not by a lack of fitness or any growth delay caused by the expression of these proteins. No HR was detectable for either the control strains or HopAJ1Pph1448a (Fig. 3b). As expected, no HR was detectable for any of the other translocated fusions (data not shown).

Figure 3.

Figure 3

Translocation assays in rps2 plants. (a) Graphical representation of ΔAvrRpt2‐dependent competitive index‐based translocation assays. PtoDC3000 wild‐type was co‐inoculated into rps2 plants with PtoDC3000 strains carrying control plasmids (left) or plasmid‐encoded candidate fusions to ΔAvrRpt2 (right). Control plasmids include the full sequence of AvrRpt2, and an AvrRpt2 protein generated by fusing its amino (amino acids 1–80) and carboxy (amino acids 81–255) terminal domains (referred to as N + C AvrRpt2), following the same cloning strategy as used to generate translational fusions to the effector candidates. Competitive indices correspond to the mean of three samples, and the error bars represent the standard error. The experiments were repeated three times with similar results. (b) ΔAvrRpt2‐dependent hypersensitive response (HR) translocation assays. PtoDC3000 strains carrying control plasmids (left) or plasmid‐encoded HopAJ1Pph1448a N‐terminal fusion to ΔAvrRpt2 (right) were inoculated into Arabidopsis rps2 plants at an optical density at 600 nm (OD600) of 0.07, and leaves were scored for HR at 24 h post‐inoculation (hpi). The photographs illustrate typical symptoms of a minimum of 80 inoculated leaves per experiment. Three independent experiments were performed with similar results.

Competitive index analysis of an HR‐triggering effector

Like AvrRpt2, some effectors are known to trigger an HR in Arabidopsis plants. One is the cysteine protease HopZ1a from P. syringae pv. syringae A2 (hereafter PsyA2) (Ma et al., 2006). We wished to determine how one of these effectors would perform in competitive index translocation assays. Thus, we carried out fusions to AvrRpt2 of HopZ1aPsyA2 and another effector of the same family, HopZ2Ppi895A. Direct translocation of HopZ2Ppi895A has not been tested previously; however, this effector has been confirmed as such on the basis of its ability to induce HR in bean when expressed from Pph1448a (Arnold et al., 2001).

When competitive index translocation assays were performed, bacteria expressing the HopZ1aPsyA2 fusion showed 100‐fold growth attenuation in wild‐type plants, and a reproducible fivefold growth attenuation in rps2 plants (Fig. 4a). Although resistance in rps2 plants is clearly weaker, it is consistently detected, thus indicating that an AvrRpt2‐independent defence response, triggered by HopZ1aPsyA2, is being detected. To confirm this result, we determined the competitive index of PtoDC3000 expressing the gene encoding the complete HopZ1aPsyA2, without AvrRpt2, in wild‐type and rps2 plants. This strain displayed a 12‐fold growth attenuation in both wild‐type and rps2 plants (Fig. 4a), confirming that HopZ1aPsyA2 activates plant defences independent of RPS2. We also determined the competitive index of PtoDC3000 expressing HopZ1aPsyA2 and AvrRpt2 simultaneously, but as separate proteins. This strain displayed a 150‐fold growth attenuation in RPS2 plants and a 20‐fold growth attenuation in rps2 plants (Fig. 4a). These results confirm that AvrRpt2 and HopZ1aPsyA2 trigger different defence responses, and also show that the effectors are less efficient in triggering HR within a fusion than they are when expressed separately. When HR assays were performed, a clear HR was visible when both wild‐type and rps2 plants were infiltrated with PtoDC3000 expressing the HopZ1aPsyA2 fusion (Fig. 4b), and a weaker HR (only 75% of the leaves showed HR symptoms) when either plant background was infiltrated with the strain expressing HopZ1aPsyA2 without AvrRpt2 (Fig. 4b).

Figure 4.

Figure 4

Translocation assays of HopZ1aPsyA2 and HopZ2Ppi895A. (a) Graphical representation of ΔAvrRpt2‐dependent competitive index‐based translocation assays. PtoDC3000 wild‐type was co‐inoculated into wild‐type (left) and rps2 (right) plants, with PtoDC3000 strains expressing HopZ1aPsyA2, HopZ1aPsyA2 together with AvrRpt2 as a polycistron, or HopZ1aPsyA2::AvrRpt2 or HopZ2aPpi895A::AvrRpt2 protein fusions. Competitive indices correspond to the mean of three samples, and the error bars represent the standard error. Experiments were repeated with similar results and pooled for statistical analysis. Results from the control plasmids from Fig. 1 are included in grey for comparison. Control plasmids include the full sequence of AvrRpt2, and an AvrRpt2 protein generated by fusing its amino (amino acids 1–80) and carboxy (amino acids 81–255) terminal domains (referred to as N + C AvrRpt2), following the same cloning strategy as used to generate translational fusions to the effector candidates. Mean values marked with the same letter were not significantly different as established by Student's t‐test (P < 0.05). (b) ΔAvrRpt2‐dependent hypersensitive response (HR) translocation assays. PtoDC3000 strains expressing fusions to ΔAvrRpt2 or HopZ1aPsyA2 were inoculated into wild‐type (left) and rps2 mutant (right) plants at an optical density at 600 nm (OD600) of 0.07, and leaves were scored for HR at 24 h post‐inoculation (hpi). Results from the control plasmids from Fig. 1 are included in grey for comparison. The photographs illustrate typical symptoms of a minimum of 80 inoculated leaves per experiment. Three independent experiments were performed with similar results.

When competitive index translocation assays were applied to the analysis of HopZ2Ppi895A, we that PtoDC3000 expressing the HopZ2Ppi895A fusion displayed a reproducible fourfold growth attenuation in wild‐type plants (Fig. 4a), thus corroborating translocation for this effector. In this case, no resistance was detected in rps2 mutant plants (Fig. 4a), indicating that this effector, unlike HopZ1aPsyA2, is not capable of inducing a defence response in Arabidopsis. Standard assays failed to demonstrate HopZ2Ppi895A translocation, as no HR symptoms could be recorded in plants infiltrated with PtoDC3000 expressing its fusion (Fig. 4b).

DISCUSSION

The HR has been used widely in the analysis of bacterium–plant interactions to determine the microbial effectors that trigger resistance (e.g. Kunkel et al., 1993), as well as the plant proteins that are required for that process (e.g. Century et al., 1997; Mindrinos et al., 1994). It is well suited for medium to high throughput because of the speed of the outcome. However, in order to obtain a fast response, a high level of bacteria must be used. Although the concentrations found in natural inoculations are in the range 105–107 colony‐forming units (cfu)/mL (Goto, 1992), closer to those used in competitive index assays, HR tests require concentrations of up to 108 cfu/mL. Using these experimental settings, it is possible to employ ΔAvrRpt2 as a reporter for the translocation of type III effectors. However, our results show that, even when inoculating a high concentration of bacteria, a high level of expression of the protein fusions is also required for the assay to work. Thus, whether or not an effector fusion is capable of triggering an HR depends on several factors, such as the level of expression from the selected promoter, the stability of the fusion protein, the efficiency of each translocation signal and the competence of the fusion to be correctly processed. These issues are particularly relevant, as we had found that fusion proteins can be less efficient than the effectors expressed as independent proteins in the triggering of plant defence responses. As standard HR assays provide semi‐quantitative results, and require a considerable level of ΔAvrRpt2 translocation inside the cell, variations in any of the above‐mentioned elements may result in a given effector fusion inducing only a mild defence response, not conducive to visible HR symptoms. Our results show that the use of competitive index analysis of strains expressing AvrRpt2 fusions to candidate effectors is an efficient way of establishing effector translocation into the plant cell. Furthermore, we have demonstrated that the ΔAvrRpt2‐based competitive index assay detects translocation in a more sensitive manner than does the standard HR assay, thus allowing the detection of TTSS‐translocated substrates failing to be revealed by standard HR assays. It should be noted that this increase in accuracy when measuring growth differences is possible as a result of the sensitivity and range of measurement provided by competitive index assays, which traditional growth assays do not provide (Macho et al., 2007). Moreover, competitive index translocation assays are carried out using bacterial concentrations closer to physiological levels (Goto, 1992), are quick and easy, and are cheaper than Cya‐based quantitative translocation assays. We also tested all of our protein fusions in a conductivity assay, as this type of analysis also provides a quantitative outcome. However, the results from the conductivity assay (Fig. S1, see ‘Supporting Information’) matched those obtained using visible HR assays, not allowing the identification of any new translocated protein.

In this study, we have demonstrated translocation for four previously unconfirmed TTSS substrates from Pph1448a: HopAJ1Pph1448a, HopAK1Pph1448a, HopAH2Pph1448a and A0129Pph1448a. There is a debate within the community about the significance of positive translocation results obtained using constitutive promoters. Our results show that very high expression of AvrRpt2 is required for any of the assays to be able to detect an HR, as only expression from the nptII promoter, but not the lacZ promoter, provides positive results. In addition, as mentioned above, we have also shown that fusion proteins can be less efficient in triggering plant defence responses than the effectors expressed independently. Therefore, our position is that, although expression in planta is a key requisite for a bona fide effector, the level of expression provided by the native promoter may be sufficient for effector biological function, but insufficient for the effective triggering of an AvrRpt2‐mediated HR, thus validating the use of constitutive promoters to show translocation.

In keeping with our results indicating that standard HR assays are not sufficiently sensitive to detect the translocation of these effectors, Chang et al. (2005) classified HopAJ1Pph1448a and HopAK1Pph1448a as not translocated. Interestingly, they showed that these two proteins are expressed in an HrpL‐dependent manner. Therefore, we believe that HopAK1Pph1448a fulfils the two criteria (i.e. HrpL‐dependent expression and translocation into the plant cell) necessary to be added to the 1448a active secretome. The homologous proteins HopAK1PmaES4326 and HopAK1PsyB728A from P. syringae pv. maculicola ES4326 (hereafter PmaES4326) and P. syringae pv. syringae B728A have both been shown to be translocated by standard HR assays (Guttman et al., 2002; Vinatzer et al., 2006). The PtoDC3000 homologue HopAK1PtoDC3000 has also been shown to translocate using the Cya reporter, albeit at a low level (Kvitko et al., 2007). Based on this low‐level translocation, these authors proposed a harpin role for HopAK1PtoDC3000 and, indeed, showed that high concentrations of partially purified protein induced HR when infiltrated into tobacco leaves. However, as the harpin concentration needed to trigger HR is non‐physiological (Tampakaki and Panopoulos, 2000), the biological significance of this activity during the infection process remains unclear. Interestingly, these authors also found that HopAK1PtoDC3000 is functionally similar to HrpK1 in promoting the translocation of effectors in PtoDC3000. The PtoDC3000 protein shares 70% identity with the Pph1448a homologue HopAK1Pph1448a, thus opening up the possibility that this homologue may also have harpin characteristics or a similar role in promoting translocation. If this were the case for the Pph1448a homologue, we would have a harpin, participating in the translocation of effectors, that is translocated itself. Such a protein may have a dual translocator/ effector role. Interestingly, HopP1 and HrpH are both translocated in PtoDC3000, and have been shown to contribute to the translocation of effectors (Oh et al., 2007).

The case of HopAJ1Pph1448a is more complex as we were unable to test the translocation of the full‐length protein because of its deleterious effect on bacterial growth. We therefore used the first 14 amino acids of HopAJ1Pph1448a to analyse the presence of a translocation signal within this protein. In keeping with our results, Vinatzer et al. (2005) found that the PmaES4326 homologue of HopAJ1 gave uncertain results when the full‐length protein was analysed for translocation, but clear positive results when only the first 14 amino acids were tested. Guttman et al. (2002) also showed a positive translocation result for HopAJ1PmaES4326, although it is not possible to establish the length of the protein tested from this report. However, using a Cya‐based assay and the full‐length protein, Oh et al. (2007) found no evidence of translocation for the PtoDC3000 homologue HopAJ1PtoDC3000. As these three homologues, HopAJ1PmaES4326, HopAJ1PtoDC3000 and HopAJ1Pph1448a, share an overall 95%–98% identity, and the first 102 amino acids from HopAJ1PmaES4326 and HopAJ1PtoDC3000 are identical, the different results observed are unlikely to be caused by differences between the proteins. Translocation of a truncated version of a protein could give misleading results if there were additional signals within the full‐length protein that could interfere with its translocation. Another explanation for the difference in the results could be that expression of the full protein fusion from PmaES4326 or PtoDC3000 may have a pleiotropic effect on bacterial growth, in a similar manner to that seen for the Pph1448a protein. Oh et al. (2007) have proposed that the PtoDC3000 homologue could be secreted into the periplasm through a putative sec domain. In such a location, it could contribute to TTSS secretion, allowing the nascent secretion system to penetrate the peptidoglycan layer by the action of its putative lytic transglycosylase domain. As our work and that of others have shown that at least some of the HopAJ1 homologues contain a functional TTSS translocation signal, further research will be necessary to fully elucidate how these proteins contribute to virulence.

Using competitive index assays, we have also demonstrated translocation of the previously untested HopAH2Pph1448a, although expression of this protein in planta would need to be determined in order for it to be considered as part of the Pph1448a active secretome. Translocation of its PtoDC3000 homologue, HopAH2PtoDC3000, has also been established using both ΔAvrRpt2‐based HR and the Cya assays (Schechter et al., 2006; Vinatzer et al., 2005). However, no expression of the PtoDC3000 hopAH2 gene has been detected in planta (Schechter et al., 2006).

Finally, we have shown translocation for the previously untested A0129Pph1448a. As the gene encoding this protein has an hrp box in the promoter region (Vencato et al., 2006), and preliminary results from our laboratory indicate that it is indeed expressed, this protein is highly likely to be part of the Pph1448a active secretome.

Using competitive index assays, we have detected no evidence of translocation for HopJ1Pph1448a, HopV1Pph1448a or HopAJ2Pph1448a. The HopJ1 and HopV1 homologues in PmaES4326 and PtoDC3000 have been shown to translocate; however their N‐terminal sequences show sufficient changes when compared with the Pph1448a proteins to justify the different results. Although it is formally possible that translocation of the Pph1448a proteins may take place at such a low level as to require new tests for their detection, it seems more probable that these proteins have lost the ability to translocate in Pph1448a as a result of patho‐adaptation. Similarly, sufficient differences can be found between the protein sequences of HopAJ2Pph1448a and HopAJ1Pph1448a to explain why one is translocated, whereas the other is not.

The analysis of HopZ1aPsyA2 by competitive index translocation assays is particularly interesting as both the tested effector and the reporter protein are capable of inducing HR in Arabidopsis. We found an increase in the level of attenuation detected by the competitive index of PtoDC3000 expressing HopZ1aPsyA2 fused to ΔAvrRpt2 (approximately 100‐fold), in comparison with that of PtoDC3000 expressing the full AvrRpt2 (20–50‐fold) (1, 4; Table S1). This increase in attenuation is consistent with an additive effect of two independent defence responses, each triggered by one of the effectors. When we determined the competitive index of PtoDC3000 expressing HopZ1aPsyA2 on its own, we observed an attenuation level close to 12‐fold. If these two defence responses were completely independent, we would have expected the competitive index of PtoDC3000 expressing HopZ1aPsyA2::ΔAvrRpt2 to show a stronger attenuation (250–600‐fold), corresponding to the added growth attenuation caused by the two responses. As effectors can undergo diverse modifications inside the plant cell leading to their activity (Coaker et al., 2005; Mudgett and Staskawicz, 1999), it is possible that the fusion of two effectors may not be as efficient in triggering defence responses as the effectors would be on their own. However, competitive index analysis of PtoDC3000 simultaneously expressing AvrRpt2 and HopZ1aPsyA2 as separate proteins showed only a 150‐fold growth attenuation in wild‐type plants. This attenuation, albeit being significantly stronger than that of the fusion protein (P < 0.05), and thus confirming a reduced efficiency of the latter in triggering defence responses, is still significantly weaker than the expected 250–600‐fold attenuation of a complete additive effect. One could argue a limitation of the assay in discriminating between strong attenuations as the reason for the difference between the observed and expected attenuation. However, we have previously detected, using competitive indices, attenuations as low as 10−4, without any loss of accuracy or sensitivity (Macho et al., 2007). Therefore, we can conclude that the defence responses induced by HopZ1aPsyA2 and AvrRpt2 are not fully additive, either because they are not completely independent, or because they can interfere with each other. In addition, the competitive index analysis of PtoDC3000 expressing HopZ1aPsyA2 in rps2 plants showed a level of attenuation not significantly different from that observed in wild‐type plants, indicating that HopZ1aPsyA2‐mediated HR is completely independent of RPS2. Whilst this work was in preparation, a study on the HopZ family requirement of myristoylation for virulence and avirulence functions also showed that HR triggered by HopZ1aPsyA2 is independent of RPS2 (Lewis et al., 2008). Correspondingly, competitive index analysis in rps2 plants of PtoDC3000 expressing HopZ1aPsyA2::ΔAvrRpt2, or the two effectors separately, is expected to reflect only the attenuation caused by the activation of the HopZ1aPsyA2‐mediated defence response. Indeed, the competitive index in rps2 plants of PtoDC3000 expressing AvrRpt2 and HopZ1aPsyA2 separately showed a level of attenuation not significantly different from that determined by the expression of HopZ1aPsyA2 alone. PtoDC3000 expressing HopZ1aPsyA2::ΔAvrRpt2 in rps2 plants displayed a fivefold attenuation, consistent with a reduced efficiency of the fusion protein in triggering the defence responses. It has been reported that AvrRpt2 promotes virulence in rps2 plants in the ecotype Nossen‐0, where the growth of PtoDC3000 is not as efficient as in ecotype Col‐0 (Chen et al., 2000). Consistent with this, we did not detect any activity associated with AvrRpt2 in promoting growth in Col‐0 rps2 plants. All of these results are compatible with HopZ1PsyA2 being both a bacterial effector that has evolved to exert a bacterial function in the plant cell, and an effector that the plant has evolved to recognize. Based on the level of resistance observed, we can speculate that HopZ1PsyA2 and AvrRpt2 are partially independent, unlike other effectors such as AvrRpm1 (Ritter and Dangl, 1996). This is consistent with the virulence target of HopZ1PsyA2 in the plant cell not being RIN4, or at least not by the same mechanism as the one used by AvrB, AvrRpm1 (Mackey et al., 2002) or AvrRpt2 (Day et al., 2005). However, the partially additive effect indicate that the plant responses to AvrRpt2 and HopZ1aPsyA2 share a component of the plant defence system. As the R gene has been discarded, the clearest candidate would be the non‐race‐specific disease resistance 1 protein (NDR1) (Century et al., 1997).

In summary, we believe that competitive index translocation assays may be useful to determine the translocation of different effector candidates from constitutive or native promoters and to characterize the avirulence responses that may be triggered by these effectors.

EXPERIMENTAL PROCEDURES

Bacterial strains and growth conditions

Bacteria were grown overnight at 37 °C for Escherichia coli DH5α (Hanahan, 1983), or for 48 h at 19 °C or 28 °C for P. syringae strains, in Luria–Bertani (LB) medium supplemented with either kanamycin (50 µg/mL for E. coli DH5α; 15 µg/mL for P. syringae strains) or cycloheximide (50 µg/mL) as appropriate.

Plasmids

The plasmids generated in this work are listed in Table 2. DNA fragments for cloning were polymerase chain reaction (PCR) amplified using Pfu polymerase (Promega, Madison, WI, USA). The genes HopZ1aPsy and HopZ2Ppi were cloned from P. syringae pv. syringae strain 7B40 (ICMP13516) and P. syringae pv. pisi strain 870A (ICMP10213), respectively, and confirmed by sequencing to be 100% identical to the corresponding effectors carried by strains PsyA2 and Ppi895A, where they were originally described. Genomic DNA of Pph1448a and Ppi870A was extracted using a Jet Flex Extraction Kit (Genomed, Löhne, Germany), and used as template for PCR amplification. A boiled preparation of Psy7B40 cells was used as template for PCR amplification. Plasmid pVSP61::avrRpt2 (Kunkel et al., 1993) was used as template for PCR amplification of avrRpt2 fragments. All oligonucleotides used for generation, as well as their restriction sites, are detailed in the ‘Supporting Information’ (Table S2). Primers included the appropriate restriction sites for cloning of the fragments into the corresponding sites of the cloning vectors (Table S2). The high‐expression plasmid pAMEX was generated by cloning the nptII gene with its own promoter at the beginning of the pBBR1MCS‐4 polylinker. A DNA fragment encoding AvrRpt2 amino acids 81–255 was amplified and tagged with the sequence encoding the FLAG epitope in a single step, and cloned into pBBR1MCS‐4 and pAMEX to create low‐ and high‐expression backbone plasmids for candidate fusions, rendering pAME5 and pAME9, respectively. Then, DNA fragments encoding the candidate open reading frames (ORFs) without the stop codon were cloned into pAME9 to create translational fusions to ΔAvrRpt2. Plasmids pAME4, pAME8 and pAME21 were generated by cloning the PCR‐amplified complete ORFs, encoding effector AvrRpt2 (pAME4 and pAME8) or HopZ1aPsyA2 (pAME21), in either pBBR1MCS‐4 (pAME4) or pAMEX (pAME8 and pAME21). Plasmid pAME23 was generated by subcloning the HopZ1aPsyA2 complete ORF from pAME21 using EcoRV into pAME8 digested with HindIII and blunt‐ended. All constructs were checked by sequencing. As indicated in the ‘Results’ section, PtoDC3000 expressing pAME9.2 showed abnormal growth and morphology (data not shown). None of the other constructs showed any effect on growth or morphology when expressed in PtoDC3000 (data not shown).

Table 2.

Plasmids used in this study.

Name Parent vector Promoter Expressed effector Reporter/tag Resistance* Reference
pBBR1‐MCS4 pBBR1‐MCS lacZ None None Amp (Kovach et al., 1995)
PAMEX pBBR1‐MCS4 nptII None None Amp, Km This work
pAME4 pBBR1‐MCS4 lacZ AvrRpt2 None Amp This work
pAME5 pBBR1‐MCS4 lacZ None AvrRpt281–255/FLAG Amp This work
pAME8 pAME4 nptII AvrRpt2 None Amp, Km This work
pAME9 pAME5 nptII None AvrRpt281–255/FLAG Amp, Km This work
pAME5.1 pAME5 lacZ AvrRpt21–80, 81–255 None Amp This work
pAME9.1 pAME9 nptII AvrRpt21–80, 81–255 None Amp, Km This work
pAME9.2 pAME9 nptII HopAJ1Pph1448a 1–388 AvrRpt281–255/FLAG Amp, Km This work
pAME9.4 pAME9 nptII HopAN1Pph1448a 1–401 AvrRpt281–255/FLAG Amp, Km This work
pAME9.5 pAME9 nptII HopJ1Pph1448a 1–157 AvrRpt281–255/FLAG Amp, Km This work
pAME9.6 pAME9 nptII HopAJ2Pph1448a 1–443 AvrRpt281–255/FLAG Amp, Km This work
pAME9.7 pAME9 nptII PSPPH37571–184 AvrRpt281–255/FLAG Amp, Km This work
pAME9.8 pAME9 nptII HopAK1Pph1448a 1–548 AvrRpt281–255/FLAG Amp, Km This work
pAME9.9 pAME9 nptII A0129Pph1448a 1–323 AvrRpt281–255/FLAG Amp, Km This work
pAME9.10 pAME9 nptII HopZ1PsyA2 1–369 AvrRpt281–255/FLAG Amp, Km This work
pAME9.11 pAME9 nptII HopZ2Ppi895A 1–362 AvrRpt281–255/FLAG Amp, Km This work
pAME9.12 pAME9 nptII ShcV + HopV1Pph1448a 1–728 AvrRpt281–255/FLAG Amp, Km This work
pAME9.13 pAME9 nptII HopAH2Pph1448a 1–416 AvrRpt281–255/FLAG Amp, Km This work
pAME9.14 pAME9 nptII HopAJ1Pph1448a 1–14 AvrRpt281–255/FLAG Amp, Km This work
pAME21 pAMEX nptII HopZ1PsyA2 None Amp, Km This work
pAME23 pAME8 nptII HopZ1PsyA2, AvrRpt2 None Amp, Km This work
*

Amp and Km indicate resistance to ampicillin and kanamycin, respectively.

HR assays

Seeds of A. thaliana accession Col‐0 or rps2 mutants (SALK_087581; European Arabidopsis Stock Centre, Nottingham, UK) were germinated and grown in growth chambers with 8‐h light/16‐h dark cycles at 21 °C light/19 °C dark. Bacterial lawns were grown for 48 h at 19 °C, resuspended in 10 mm MgCl2 and adjusted to an optical density at 600 nm (OD600) of 0.07. Fully expanded leaves of 4–5‐week‐old plants were inoculated using a 2‐mL syringe without needle, and symptoms were scored 24 h post‐inoculation (hpi). Three independent experiments were carried out with each strain with similar results. Approximately 80 leaves were infiltrated per experiment and strain.

Competitive index translocation assays

Competitive index assays to measure growth attenuation were performed as described for Arabidopsis plants (Macho et al., 2007). Briefly, seeds of A. thaliana accession Col‐0 or rps2 mutants were germinated and grown in growth chambers with 8‐h light/16‐h dark cycles at 21 °C. Four‐ to five‐week‐old plants were inoculated with a 5 × 104 cfu/mL mixed bacterial suspension, containing equal cfu of wild‐type and effector‐expressing strains, using a 2‐mL syringe without needle. Serial dilutions of the inoculum were plated onto LB agar and LB agar with kanamycin to confirm the dose and relative proportion between the strains, which should be close to unity. Four days post‐inoculation (dpi), bacteria were recovered from the infected leaves by taking three 10‐mm‐diameter discs with a cork‐borer, which were homogenized by mechanical disruption into 1 mL of 10 mm MgCl2. The bacteria were then enumerated by plating serial dilutions onto LB agar with cycloheximide and LB agar with kanamycin and cycloheximide to differentiate between the strains within the mixed infection. Bacterial enumeration was carried out in the dilution displaying between 50 and 500 colonies per plate. A competitive index in a translocation assay is defined as the effector expressing to weight output ratio divided by the input ratio. Competitive indices are the means of three replicates showing typical results of three independent experiments. Error bars represent the standard error. Each competitive index was analysed using a homoscedastic and two‐tailed Student's t‐test and the null hypothesis: the mean index is not significantly different from unity, or from another competitive index when otherwise specified (with P < 0.05 used).

Supporting information

Fig. S1 Conductivity assays for HR detection. Pto DC3000 strains expressing either AvrRpt2 or any of the candidate fusions were inoculated into Arabidopsis Col‐0 (RPS2/RPS2) wild type, at an OD600 of 0.1. Three leaf disks (corresponding to a 1.15 cm2 area) were harvested, per each sample, at 16 hours post‐inoculation, soaked in water for 45 minutes and transferred to 5 mL of dH2O. Readings were taken with a Crison 524 conductivity meter (Crison Instruments S.A., Barcelona, Spain). Results show the mean of three replicates, and error bars represent standard error. An MgCl2 10 mM solution, and a Pto DC3000 wild type suspension, were used as mock inoculation and negative control, respectively.

Table S1 Competitive indices corresponding to Figs 1–4 of this paper.

Table S2 Oligonucleotides used in this study.

Please note: Wiley‐Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.

Supporting info item

Supporting info item

Supporting info item

ACKNOWLEDGEMENTS

We thank T. Duarte and L. Perales for technical assistance, and E. R. Bejarano for valuable discussions. C. R. Beuzón was supported by the ‘Ramón y Cajal’ Programme from the Ministerio de Ciencia y Tecnología. This work was supported by a Project Grant (BIO2006‐00673) from the Ministerio de Educación y Ciencia (Spain) to C. R. Beuzón. This work was co‐funded by Fondo Europeo de Desarrollo Regional (FEDER).

REFERENCES

  1. Alfano, J.R. and Collmer, A. (1997) The type III (Hrp) secretion pathway of plant pathogenic bacteria: trafficking harpins, Avr proteins, and death. J. Bacteriol. 179, 5655–5662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alfano, J.R. and Collmer, A. (2004) Type III secretion system effector proteins: double agents in bacterial disease and plant defense. Annu. Rev. Phytopathol. 42, 385–414. [DOI] [PubMed] [Google Scholar]
  3. Arnold, D.L. , Jackson, R.W. , Fillingham, A.J. , Goss, S.C. , Taylor, J.D. , Mansfield, J.W. and Vivian, A. (2001) Highly conserved sequences flank avirulence genes: isolation of novel avirulence genes from Pseudomonas syringae pv. pisi. Microbiology, 147, 1171–1182. [DOI] [PubMed] [Google Scholar]
  4. Boch, J. , Joardar, V.I.G.L. , Robertson, T.L. , Lim, M. and Kunkel, B.N. (2002) Identification of Pseudomonas syringae pv. tomato genes induced during infection of Arabidopsis thaliana . Mol. Microbiol. 44, 73–88. [DOI] [PubMed] [Google Scholar]
  5. Century, K.S. , Shapiro, A.D. , Repetti, P.P. , Dahlbeck, D. , Holub, E. and Staskawicz, B.J. (1997) NDR1, a pathogen‐induced component required for Arabidopsis disease resistance. Science, 278, 1963–1965. [DOI] [PubMed] [Google Scholar]
  6. Chang, J.H. , Urbach, J.M. , Law, T.F. , Arnold, L.W. , Hu, A. , Gombar, S. , Grant, S.R. , Ausubel, F.M. and Dangl, J.L. (2005) A high‐throughput, near‐saturating screen for type III effector genes from Pseudomonas syringae . Proc. Natl. Acad. Sci. 102, 2549–2554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen, Z. , Kloek, A.P. , Boch, J. , Katagiri, F. and Kunkel, B.N. (2000) The Pseudomonas syringae avrRpt2 gene product promotes pathogen virulence from inside plant cells. Mol. Plant–Microbe Interact. 13, 1312–1321. [DOI] [PubMed] [Google Scholar]
  8. Coaker, G. , Falick, A. and Staskawicz, B. (2005) Activation of a phytopathogenic bacterial effector protein by a eukaryotic cyclophilin. Science, 308, 548–550. [DOI] [PubMed] [Google Scholar]
  9. Day, B. , Dahlbeck, D. , Huang, J. , Chisholm, S.T. , Li, D. and Staskawicz, B.J. (2005) Molecular basis for the RIN4 negative regulation of RPS2 disease resistance. Plant Cell, 17, 1292–1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goto, M. (1992) Fundamentals of Bacterial Plant Pathology. New York: Academic Press. [Google Scholar]
  11. Guttman, D.S. , Vinatzer, B.A. , Sarkar, S.F. , Ranall, M.V. , Kettler, G. and Greenberg, J.T. (2002) A functional screen for the type III (Hrp) secretome of the plant pathogen Pseudomonas syringae . Science, 295, 1722–1726. [DOI] [PubMed] [Google Scholar]
  12. Hanahan, D. (1983) Studies of transformation of Escherichia coli with plasmids. J. Mol. Biol. 166, 557–580. [DOI] [PubMed] [Google Scholar]
  13. Joardar, V. , Lindeberg, M. , Jackson, R.W. , Selengut, J. , Dodson, R. , Brinkac, L.M. , Daugherty, S.C. , Deboy, R. , Durkin, A.S. , Giglio, M.G. , Madupu, R. , Nelson, W.C. , Rosovitz, M.J. , Sullivan, S. , Crabtree, J. , Creasy, T. , Davidsen, T. , Haft, D.H. , Zafar, N. , Zhou, L. , Halpin, R. , Holley, T. , Khouri, H. , Feldblyum, T. , White, O. , Fraser, C.M. , Chatterjee, A.K. , Cartinhour, S. , Schneider, D.J. , Mansfield, J. , Collmer, A. and Buell, C.R. (2005) Whole‐genome sequence analysis of Pseudomonas syringae pv. phaseolicola 1448A reveals divergence among pathovars in genes involved in virulence and transposition. J. Bacteriol. 187, 6488–6498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kovach, M.E. , Elzer, P.H. , Hill, D.S. , Robertson, G.T. , Farris, M.A. , Roop, R.M. 2nd and Peterson, K.M. (1995) Four new derivatives of the broad‐host‐range cloning vector pBBR1MCS, carrying different antibiotic‐resistance cassettes. Gene, 166, 175–176. [DOI] [PubMed] [Google Scholar]
  15. Kunkel, B.N. , Bent, A.F. , Dahlbeck, D. , Innes, R.W. and Staskawicz, B.J. (1993) RPS2, an Arabidopsis disease resistance locus specifying recognition of Pseudomonas syringae strains expressing the avirulence gene avrRpt2 . Plant Cell, 5, 865–875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kvitko, B.H. , Ramos, A.R. , Morello, J.E. , Oh, H.S. and Collmer, A. (2007) Identification of harpins in Pseudomonas syringae pv. tomato DC3000, which are functionally similar to HrpK1 in promoting translocation of type III secretion system effectors. J. Bacteriol. 189, 8059–8072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lewis, J.D. , Abada, W. , Ma, W. , Guttman, D.S. and Desveaux, D. (2008) The HopZ family of Pseudomonas syringae type III effectors require myristoylation for virulence and avirulence functions in Arabidopsis thaliana . J. Bacteriol. 190, 2880–2891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lindeberg, M. , Stavrinides, J. , Chang, J.H. , Alfano, J.R. , Collmer, A. , Dangl, J.L. , Greenberg, J.T. , Mansfield, J.W. and Guttman, D.S. (2005) Proposed guidelines for a unified nomenclature and phylogenetic analysis of type III Hop effector proteins in the plant pathogen Pseudomonas syringae . Mol. Plant–Microbe Interact. 18, 275–282. [DOI] [PubMed] [Google Scholar]
  19. Lindeberg, M. , Cartinhour, S. , Myers, C.R. , Schechter, L.M. , Schneider, D.J. and Collmer, A. (2006) Closing the circle on the discovery of genes encoding Hrp regulon members and type III secretion system effectors in the genomes of three model Pseudomonas syringae strains. Mol. Plant–Microbe Interact. 19, 1151–1158. [DOI] [PubMed] [Google Scholar]
  20. Ma, W. , Dong, F.F. , Stavrinides, J. and Guttman, D.S. (2006) Type III effector diversification via both pathoadaptation and horizontal transfer in response to a coevolutionary arms race. PLoS Genet. 2, e209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Macho, A.P. , Zumaquero, A. , Ortiz‐Martin, I. and Beuzon, C.R. (2007) Competitive index in mixed infections: a sensitive and accurate assay for the genetic analysis of Pseudomonas syringae–plant interactions. Mol. Plant Pathol. 8, 437–450. [DOI] [PubMed] [Google Scholar]
  22. Mackey, D. , Holt, B.F. 3rd , Wiig, A. and Dangl, J.L. (2002) RIN4 interacts with Pseudomonas syringae type III effector molecules and is required for RPM1‐mediated resistance in Arabidopsis. Cell, 108, 743–754. [DOI] [PubMed] [Google Scholar]
  23. Mindrinos, M. , Katagiri, F. , Yu, G.L. and Ausubel, F.M. (1994) The A. thaliana disease resistance gene RPS2 encodes a protein containing a nucleotide‐binding site and leucine‐rich repeats. Cell, 78, 1089–1099. [DOI] [PubMed] [Google Scholar]
  24. Mudgett, M.B. and Staskawicz, B.J. (1999) Characterization of the Pseudomonas syringae pv. tomato AvrRpt2 protein: demonstration of secretion and processing during bacterial pathogenesis. Mol. Microbiol. 32, 927–941. [DOI] [PubMed] [Google Scholar]
  25. Mudgett, M.B. , Chesnokova, O. , Dahlbeck, D. , Clark, E.T. , Rossier, O. , Bonas, U. and Staskawicz, B.J. (2000) Molecular signals required for type III secretion and translocation of the Xanthomonas campestris AvrBs2 protein to pepper plants. Proc. Natl. Acad. Sci. USA, 97, 13 324–13 329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Oh, H.S. , Kvitko, B.H. , Morello, J.E. and Collmer, A. (2007) Pseudomonas syringae lytic transglycosylases coregulated with the type III secretion system contribute to the translocation of effector proteins into plant cells. J. Bacteriol. 189, 8277–8289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Petnicki‐Ocwieja, T. , Schneider, D.J. , Tam, V.C. , Chancey, S.T. , Shan, L. , Jamir, Y. , Schechter, L.M. , Janes, M.D. , Buell, C.R. , Tang, X. , Collmer, A. and Alfano, J.R. (2002). Genomewide identification of proteins secreted by the Hrp type III protein secretion system of Pseudomonas syringae pv. tomato DC3000. Proc. Natl. Acad. Sci. USA, 99, 7652–7657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Ritter, C. and Dangl, J.L. (1996) Interference between two specific pathogen recognition events mediated by distinct plant disease resistance genes. Plant Cell, 8, 251–257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schechter, L.M. , Roberts, K.A. , Jamir, Y. , Alfano, J.R. and Collmer, A. (2004) Pseudomonas syringae type III secretion system targeting signals and novel effectors studied with a Cya translocation reporter. J. Bacteriol. 186, 543–555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schechter, L.M. , Vencato, M. , Jordan, K.L. , Schneider, S.E. , Schneider, D.J. and Collmer, A. (2006) Multiple approaches to a complete inventory of Pseudomonas syringae pv. tomato DC3000 type III secretion system effector proteins. Mol. Plant–Microbe Interact. 19, 1180–1192. [DOI] [PubMed] [Google Scholar]
  31. Sundin, G.W. , Mayfield, C.T. , Zhao, Y. , Gunasekera, T.S. , Foster, G.L. and Ullrich, M.S. (2004) Complete nucleotide sequence and analysis of pPSR1 (72 601 bp), a pPT23A‐family plasmid from Pseudomonas syringae pv. syringae A2. Mol. Genet. Genomics, 270, 462–476. [DOI] [PubMed] [Google Scholar]
  32. Tampakaki, A.P. and Panopoulos, N.J. (2000) Elicitation of hypersensitive cell death by extracellularly targeted HrpZPsph produced in planta. Mol. Plant–Microbe Interact. 13, 1366–1374. [DOI] [PubMed] [Google Scholar]
  33. Vencato, M. , Tian, F. , Alfano, J.R. , Buell, C.R. , Cartinhour, S. , DeClerck, G.A. , Guttman, D.S. , Stavrinides, J. , Joardar, V. , Lindeberg, M. , Bronstein, P.A. , Mansfield, J.W. , Myers, C.R. , Collmer, A. and Schneider, D.J. (2006) Bioinformatics‐enabled identification of the HrpL regulon and type III secretion system effector proteins of Pseudomonas syringae pv. phaseolicola 1448A. Mol. Plant–Microbe Interact. 19, 1193–1206. [DOI] [PubMed] [Google Scholar]
  34. Vinatzer, B.A. , Jelenska, J. and Greenberg, J.T. (2005) Bioinformatics correctly identifies many type III secretion substrates in the plant pathogen Pseudomonas syringae and the biocontrol isolate P. fluorescens SBW25. Mol. Plant–Microbe Interact. 18, 877–888. [DOI] [PubMed] [Google Scholar]
  35. Vinatzer, B.A. , Teitzel, G.M. , Lee, M.W. , Jelenska, J. , Hotton, S. , Fairfax, K. , Jenrette, J. and Greenberg, J.T. (2006) The type III effector repertoire of Pseudomonas syringae pv. syringae B728a and its role in survival and disease on host and non‐host plants. Mol. Microbiol. 62, 26–44. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Fig. S1 Conductivity assays for HR detection. Pto DC3000 strains expressing either AvrRpt2 or any of the candidate fusions were inoculated into Arabidopsis Col‐0 (RPS2/RPS2) wild type, at an OD600 of 0.1. Three leaf disks (corresponding to a 1.15 cm2 area) were harvested, per each sample, at 16 hours post‐inoculation, soaked in water for 45 minutes and transferred to 5 mL of dH2O. Readings were taken with a Crison 524 conductivity meter (Crison Instruments S.A., Barcelona, Spain). Results show the mean of three replicates, and error bars represent standard error. An MgCl2 10 mM solution, and a Pto DC3000 wild type suspension, were used as mock inoculation and negative control, respectively.

Table S1 Competitive indices corresponding to Figs 1–4 of this paper.

Table S2 Oligonucleotides used in this study.

Please note: Wiley‐Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.

Supporting info item

Supporting info item

Supporting info item


Articles from Molecular Plant Pathology are provided here courtesy of Wiley

RESOURCES